You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Reserach/Researchers Articles
Popular Reserach/Researchers Articles
Highly Recommended Reserach/Researchers Articles
Send a link to this page to your friends and colleagues.
Scientists meeting recently at the International Liver Congress in Barcelona, Spain, say that microbiota-tiny organisms specific to a part of the body-transplanted from healthy people to people at risk of diabetes or nonalcoholic fatty liver disease may prevent the later onset of those conditions. The procedure involves implanting small quantities of fecal matter from healthy donors into the colons of pre-diseased recipients.
French scientists conducted a 16-week study on two sets of germ-free mice. The first set was given microbiota from the colons of donor mice that displayed symptoms of insulin resistance and fatty build-up in the liver. The second set received gut microbiota from mice that had neither symptom.
The mice that received microbiota from the symptomatic mice began showing higher levels of insulin resistance and concentrations of fat in the liver. The second set of mice showed no significant changes in insulin sensitivity, glucose levels, or liver fat.
The transplantation of microbiota via fecal matter has been a topic of discussion for several years. Although the approach seems counter-intuitive, given the association of feces with germs and disease, research increasingly confirms that it shows great promise. In previous cases when the procedure, called fecal bacteriotherapy, was used to treat colitis and other bowel ailments, transplants were often made from one family member to another.
0 comments - May 18, 2012
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.